Merck & Co., Inc. (NYSE:MRK) Gets FDA Nod For ZERBAXA

Donna Fago - June 4, 2019

Merck & Co., Inc. (NYSE:MRK) reported that the U.S. Food and Drug Administration has approved expanded use of its antibiotic to cure hospital-acquired pneumonia in people 18 years and older....

Sign Up To Get Our Latest Stocks Alerts